Qué Hacemos
Behaivior tiene la misión de democratizar la recuperación de las adicciones y la salud mental mediante el uso de inteligencia artificial, tecnología de salud conductual y dispositivos portátiles para la prevención de crisis y el apoyo a la salud mental. Ayudamos a las personas a seguir adelante con su proceso de recuperación brindándoles la intervención adecuada en el momento adecuado, en tiempo real. Ayudamos a los proveedores de atención médica a brindar un mejor servicio a sus clientes y a los empleadores a brindar un mejor servicio a sus empleados.
![Un grupo de oradores de TEDxPittsburgh 2018 [small worlds] de pie en el escenario. En este evento TED, los oradores exploraron temas que conectan a las personas a travĆ©s de fronteras, industrias y tiempo. Escucharon ideas sobre la recuperaciĆ³n de desastres, el avance de la investigaciĆ³n del cĆ”ncer de mama, el uso de IA para combatir la epidemia de opioides, el liderazgo en las ciudades y mĆ”s. AquĆ, la fundadora y directora ejecutiva de Behaivior, Ellie Gordon, dio una charla sobre cĆ³mo la inteligencia artificial y los dispositivos portĆ”tiles pueden combatir la adicciĆ³n a los opioides.](https://static.wixstatic.com/media/39d31e_1f9b41e923854418ac04d109ea2e5c3d~mv2.jpg/v1/crop/x_32,y_1,w_241,h_240/fill/w_261,h_261,al_c,lg_1,q_80,enc_avif,quality_auto/Behaivior%20Team%20Images.jpg)
SAMHSA (The Substance Abuse and Mental Health Services Administration) define la recuperación como:
"A process of change through which individuals improve their health and wellness, live a self-directed life, and strive to reach their full potential."
¿Por qué Recovery?
Behaivior adopta la definición de recuperación de SAMHSA y cree que todas las personas tienen derecho a las herramientas necesarias para tener éxito en su camino hacia la recuperación y alcanzar su máximo potencial.
ā
Con tasas de sobredosis y crisis de salud mental más altas que nunca, se necesita un nuevo enfoque.
¿Cómo Podemos Ayudar?
Meet Recovery™. A toolbox at your fingertips. Health care providers can use our company, Behaivior, to know in advance when individuals are in a high-risk state, and vulnerable to a crisis event, including use or return to use. Behaivior uses advanced AI behavioral health technology, and wearables to collect biometrics, provide proactive interventions, and more to help individuals be successful in their recovery.
ā
Behaivior uses proprietary AI-enabled predictions of upcoming pre-crisis events, including return to use, and detailed assessment summaries. Users can access digital interventions and choose to alert their care providers and support networks of high-probability risk events.
Behavior was founded in Pittsburgh, Pennsylvania, USA, in an effort to take action to address the opioid epidemic. We are driven to and passionate about improving the lives of others and enacting positive change on a global scale. Behavior is comprised of a diverse team of experts with professional backgrounds, including business, UI/UX design, addiction and mental health science, consumer and behavioral technology, software development, human-computer interaction, artificial intelligence, and machine learning experience. They have successfully developed, deployed, and evaluated treatment support solutions for chronic disease management, medication reconciliation, and workflow management.
Ellie Gordon (she/her)
Founder & CEO
Ellie Gordon, Behaivior Founder and CEO, is a behavioral technologist, innovator, designer, and entrepreneur. For over 15 years, her work has primarily focused on improving individual's lives through technology. She has successfully created, organized, led, and managed teams for everything from hackathons and code fests to other science-based startups and initiatives, to community development and research projects. She did a TEDx talk as a behavioral technologist speaking about the design elements of what Behaivior is developing. Since founding Behaivior in January 2017, she has led a growing team to win multiple competitions, grants, and entrance into multiple startup incubator and accelerator programs, including winning the Carnegie Science Award, being a finalist for the Tech Top 50, for CEO of the Year, and for the Athena Award, participating in the Ignite Healthcare program, AlphaLab, and being in the top 10 in the world for both the first and second milestones of the global IBM Watson AI XPRIZE competition. Ellie is an alumna of the Yale Innovation to Impact Fellowship program, winning a pitch award, and was also featured as a New Generation Tech Entrepreneur by the Pittsburgh Tech Council.
%20(1).jpg)
Dr. John Richey (he/him)
Technical Lead
Dr. John Richey, technical lead: As Principal Scientist, his expertise lies at the intersection of data science, human decision-making, and computational neuroscience. His career objective is to leverage this expertise in order to translate human-centered data into digital platforms that meaningfully improve our lives. He is a “full-stack” scientist with more than 13 years of experience in end-to-end design, management, and publication of NIH-funded, ethical research. His specific background is in advanced data analytics including machine learning, neural signal processing (EEG, fMRI, fNIRS), mobile/app-based technology, computational modeling and experimental methodology. In this role, he leads, mentors, and coordinates the activities of an interdisciplinary team that applies data science techniques in concert with rigorous scientific frameworks to rapidly push theoretical work into real world settings.
.png)
Whitney I. Menarcheck, LPC (she/her)
Clinical Applications Director
Whitney is a Licensed Professional Counselor in the Commonwealth of Pennsylvania. Determined to eliminate barriers and cultivate opportunities for others to achieve their self-defined success, meaning, and fulfillment, Whitney leverages her 10+ years of experience working with individuals in recovery and their families to deliver innovative solutions that support the individual in their recovery journey. A persistent advocate for the populations she serves, Whitney is committed to value- and evidence-based approaches to substance use and mental health disorders. She is regarded as a leading expert in the field of addiction treatment, as evidenced by her presence on the editorial board for the forthcoming The ASAM Criteria, 4th Edition, and serving as the lead editor for content on assessment, reassessment, and measurement based care. With a background in leading treatment and service programs, serving as a member of senior healthcare management, and working directly with individuals with behavioral health disorders, she brings knowledge and experience that enhances the application, adoption, and effective utilization of Behaivior's technology in behavioral health settings.